 | Up a level |
Hounsome, L, Eyre, TA, Ireland, R, Hodson, A, Walewska, R, Ardeshna, K, Chaganti, S, McKay, P, Davies, A, Fox, CP et al (show 2 more authors)
(2022)
Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England.
BRITISH JOURNAL OF CANCER, 126 (1).
pp. 134-143.
Pettitt, AR, Polydoros, F, Dodd, J, Oates, M, Lin, K, Kalakonda, N, McCarthy, H, Bloor, A, Schuh, A, Duncombe, A et al (show 6 more authors)
(2016)
FINAL RESULTS OF THE NCRI CLL210 TRIAL OF ALEMTUZUMAB, DEXAMETHASONE AND LENALIDOMIDE IN PATIENTS WITH HIGH-RISK CLL (ORIGINAL PROTOCOL).
.
Iyer, D, Vartak, SV, Mishra, A, Goldsmith, G, Kumar, S, Srivastava, M, Hegde, M, Gopalakrishnan, V, Glenn, M, Velusamy, M et al (show 5 more authors)
(2016)
Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain.
The Federation of European Biochemical Societies (FEBS) Journal, 283 (18).
pp. 3408-3437.
Duckworth, AD, Gherardini, PF, Sykorova, M, Yasin, F, Nolan, GP, Slupsky, JR 
ORCID: 0000-0002-7410-9004 and Kalakonda, N ORCID: 0000-0002-5300-1360
(2019)
Multiplexed profiling of RNA and protein expression signatures in individual cells using flow or mass cytometry.
Nature Protocols, 14 (03).
pp. 901-920.